Literature DB >> 371796

Pharmacokinetics and metabolism of ftorafur in man.

J L Au, A T Wu, M A Friedman, W Sadée.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 371796

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  10 in total

1.  Potentiation of the chemotherapeutic action of tegafur against solid adenocarcinoma 755 by combination with L-cystine.

Authors:  M Iigo; A Hoshi; H Kitagawa
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

2.  Tegafur and 5-fluorouracil pelvic tissue concentrations in rectal cancer patients receiving preoperative chemoradiation.

Authors:  F A Calvo; A Aldaz; L Zufía; D de la Mata; J Serrano; R García; J A Arranz; A Alvarado; J Giráldez
Journal:  Clin Transl Oncol       Date:  2006-07       Impact factor: 3.405

3.  Stereoselective metabolism of ftorafur (R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil).

Authors:  J L Au; W Sadée
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

4.  Hepatic conversion of 1-(tetrahydro-2-furanyl)-5-fluorouracil into 5-fluorouracil in patients with hepatocellular carcinoma.

Authors:  S Kawata; S Noda; Y Imai; S Tamura; R Saitoh; S Miyoshi; Y Minami; S Tarui
Journal:  Gastroenterol Jpn       Date:  1987-02

5.  Changes in toxic and antitumor properties of ftorafur by induction or inhibition of the microsomal enzymes activity.

Authors:  G A Belitsky; V M Bukhman; I A Konopleva
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

6.  Pharmacokinetics of ftorafur after intravenous and oral administration.

Authors:  M I Anttila; E A Sotaniemi; M I Kairaluoma; R E Mokka; H T Sundquist
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

7.  Measurement of in vitro cellular pharmacokinetics of 5-fluorouracil in human and rat cancer cell lines and rat hepatocytes using a flow-through system.

Authors:  E C Spoelstra; H M Pinedo; H Dekker; G J Peters; J Lankelma
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

8.  Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study.

Authors:  S Palmeri; V Gebbia; A Russo; M G Armata; N Gebbia; L Rausa
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

9.  Phase II trial of UFT in advanced colorectal and gastric cancer.

Authors:  S T Malik; D Talbot; P I Clarke; R Osborne; R Reznek; P F Wrigley; M L Slevin
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

Review 10.  Emerging role of S-1 in gastric cancer.

Authors:  Eriseld Krasniqi; Stefania Pellicori; Vincenzo Formica
Journal:  Indian J Med Paediatr Oncol       Date:  2015 Oct-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.